Ovarian Cysts Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cysts, including details on causes, treatment, symptoms, infertility.

Volume 6 (2009), Issue 4 (April)

1. Genetic variations of solute carrier family 30 (zinc transporter) member 8 (SLC30A8) are not associated with polycystic ovary syndrome.
   Fertil Steril, 91(4): 1598-601. [Abstract] [Full-text]
2. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
   Fertil Steril, 91(4): 1533-5. [Abstract] [Full-text]
3. Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
   Fertil Steril, 91(4): 1563-7. [Abstract] [Full-text]
4. Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome.
   Fertil Steril, 91(4): 1493-5. [Abstract] [Full-text]
5. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
   Fertil Steril, 91(4): 1466-8. [Abstract] [Full-text]
6. Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome.
   Fertil Steril, 91(4): 1437-40. [Abstract] [Full-text]
7. Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome.
   Fertil Steril, 91(4): 1336-8. [Abstract] [Full-text]
8. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.
   Fertil Steril, 91(4): 1332-5. [Abstract] [Full-text]
9. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.
   Br J Cancer, 100(8): 1315-9. [Abstract] [Full-text]
10. Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.
    Metabolism, 58(5): 714-21. [Abstract] [Full-text]
11. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Metabolism, 58(5): 586-93. [Abstract] [Full-text]
12. Discussion: 'Novel clomiphene protocol in polycystic ovarian syndrome' by Hurst et al.
    Am J Obstet Gynecol, 200(5): e1-3. [Abstract] [Full-text]
13. Novel clomiphene "stair-step" protocol reduces time to ovulation in women with polycystic ovarian syndrome.
    Am J Obstet Gynecol, 200(5): 510.e1-4. [Abstract] [Full-text]
14. Effect of Korean red ginseng extract in a steroid-induced polycystic ovary murine model.
    Arch Pharm Res, 32(3): 347-52. [Abstract] [Full-text]
15. Androgens and polycystic ovary syndrome.
    Curr Opin Endocrinol Diabetes Obes, 16(3): 224-31. [Abstract] [Full-text]
16. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.
    Eur J Endocrinol, 160(5): 855-62. [Abstract] [Full-text]
17. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
    Eur J Endocrinol, 160(5): 847-53. [Abstract] [Full-text]

© 2004-2010 Ovarian Cysts Research Today. All Rights Reserved.